Juvena Therapeutics is Drug Discovery in United States that focus on platform screens business. Founded in 2017. They cover business area such as developer, biopharmaceutical drug discovery platform, novel protein-base therapeutic, muscle stem cell function, tissue regeneration, initial clinical target, sarcopenia, muscle regeneration, healthcare professional, patient, loss, homeostasis, apply human protein therapy.
2017
( 7 years old in 2024 )
Platform Screens
-
2627 Hanover Street
Palo Alto, CA 94304
United States
Private
developerbiopharmaceutical drug discovery platformnovel protein-base therapeuticmuscle stem cell functiontissue regenerationinitial clinical targetsarcopeniamuscle regenerationhealthcare professionalpatientlosshomeostasisapply human protein therapy
* We use standard office opening hours in near Juvena Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Juvena Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Juvena Therapeutics business is focusing on Platform Screens.
Juvena Therapeutics headquarter office and corporate office address is located in 2627 Hanover Street Palo Alto, CA 94304 United States.
Juvena Therapeutics was founded in United States.
In 2024, Juvena Therapeutics is currently focus on platform screens sector.
Above is snippet of Google Trends for "platform screens" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Juvena Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
